Eric Freund
Impact in
-
- Plasma Applications and Diagnostics
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Plasma Applications and Diagnostics 39
- Immunology 11
- Immune cells in cancer 6
- Immunotherapy and Immune Responses 4
- Co-authors
- Sander Bekeschus (48 shared papers)Lars-Ivo Partecke (12 shared papers)Kim Rouven Liedtke (9 shared papers)Anke Schmidt (9 shared papers)Ramona Clemen (10 shared papers)Lea Miebach (16 shared papers)Thomas von Woedtke (12 shared papers)Claus-Dieter Heidecke (5 shared papers)
- Journals
- Cancers (8 papers)International Journal of Molecular Sciences (4 papers)Advanced Science (4 papers)Antioxidants (4 papers)Applied Sciences (3 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Eric Freund
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 70
- Radiology, Nuclear Medicine and Imaging 1k
- Immunology 112
- Rehabilitation 19
- Oncology 56
- Biotechnology 16
Countries citing papers authored by Eric Freund
This map shows the geographic impact of Eric Freund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Freund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Freund more than expected).
Fields of papers citing papers by Eric Freund
This network shows the impact of papers produced by Eric Freund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Freund. The network helps show where Eric Freund may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Freund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 132 | |
| 2 | 2020 | 112 | |
| 3 | 2022 | 62 | |
| 4 | 2021 | 57 | |
| 5 | 2020 | 48 | |
| 6 | 2022 | 47 | |
| 7 | 2019 | 45 | |
| 8 | 2018 | 44 | |
| 9 | 2019 | 44 | |
| 10 | 2020 | 44 | |
| 11 | 2018 | 43 | |
| 12 | 2020 | 37 | |
| 13 | 2020 | 35 | |
| 14 | 2021 | 33 | |
| 15 | 2019 | 32 | |
| 16 | 2018 | 30 | |
| 17 | 2020 | 30 | |
| 18 | 2019 | 28 | |
| 19 | 2020 | 27 | |
| 20 | 2020 | 26 |
About Eric Freund
Eric Freund is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Genetics, Oncology and Toxicology, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Plasma Applications and Diagnostics (39 papers), Immune cells in cancer (6 papers), Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Glioma Diagnosis and Treatment (3 papers), Redox biology and oxidative stress (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Oral Health Pathology and Treatment (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1k citations), Immunology (112 citations), Rehabilitation (19 citations), Oncology (56 citations) and Biotechnology (16 citations). Eric Freund has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Sander Bekeschus, Lars-Ivo Partecke, Kim Rouven Liedtke, Anke Schmidt, Ramona Clemen, Lea Miebach, Thomas von Woedtke, Claus-Dieter Heidecke, Kristian Wende and Hans‐Robert Metelmann. Their work appears in journals such as Cancers, International Journal of Molecular Sciences, Advanced Science, Antioxidants and Applied Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.